![](/img/cover-not-exists.png)
Phase I Trial of Brentuximab Vedotin for Steroid-Refractory Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
DeFilipp, Zachariah, Li, Shuli, Kempner, Maria E., Brown, Jami, Del Rio, Candice, Valles, Betsy, Hunnewell, Chrisa, Saylor, Meredith, Vanderklish, Julie, Dey, Bimalangshu R., El-Jawahri, Areej, McAfeeLanguage:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2018.05.012
Date:
May, 2018
File:
PDF, 391 KB
english, 2018